Degenerative effects of various neurotoxic indoleamines on central monoamine neurons.
D015115:5,6-Dihydroxytryptamine / Q000378:metabolism / Q000494:pharmacology; D015116:5,7-Dihydroxytryptamine / Q000378:metabolism / Q000494:pharmacology; D000818:Animals; D001369:Axons / Q000187:drug effects; D002395:Catecholamines / Q000378:metabolism / Q000502:physiology*; D002490:Central Nervous System / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D003891:Desipramine / Q000494:pharmacology; D066298:In Vitro Techniques; D009474:Neurons / Q000187:drug effects*; D012701:Serotonin / Q000378:metabolism / Q000502:physiology*; D014363:Tryptamines / Q000494:pharmacology*
D002395:Catecholamines; D014363:Tryptamines; D015116:5,7-Dihydroxytryptamine; D012701:Serotonin; D003891:Desipramine; D015115:5,6-Dihydroxytryptamine